1. What BPC157 & TB500 10 mg is and what it is used for
BPC157 & TB500 is a dual-peptide injectable research compound combining two peptides studied for their potential regenerative properties.
BPC-157
BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from a protective stomach protein.
Research suggests potential roles in:
Tissue repair and regeneration
Angiogenesis (formation of new blood vessels)
Reduction of inflammation
Gastrointestinal tissue protection
TB-500 (Thymosin Beta-4 Fragment)
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide involved in:
Cellular migration
Tissue regeneration
Wound healing
Cytoskeletal organization
Key Research Applications
The combination of BPC157 and TB500 is commonly studied for:
Recovery of muscle injuries
Repair of tendons and ligaments
Joint tissue regeneration
Enhancement of soft tissue healing
Improvement in mobility and flexibility
These two peptides are often combined due to their synergistic regenerative mechanisms, supporting systemic tissue repair in research settings.
2. What you need to know before using BPC157 & TB500 10 mg
Do not use BPC157 & TB500 if you:
Are allergic to BPC-157 or TB-500
Are pregnant or breastfeeding
Are not trained in injection or laboratory protocols
Warnings and precautions
This product is not approved for therapeutic or medical use
Intended strictly for laboratory or research purposes
Not recommended for individuals under 18 years of age
Consult a qualified professional if:
Injection site irritation occurs
You have bleeding disorders
You are taking anticoagulants
You are using other peptide compounds
Interactions
Avoid combining with other injectables unless part of a controlled research protocol.
3. How to use BPC157 & TB500 10 mg
Always follow research protocols or practitioner instructions when preparing or administering this compound.
Product Format
1 sterile vial
Contains 10 mg total peptides
5 mg BPC-157
5 mg TB-500
The vial typically contains lyophilized powder and must be reconstituted with sterile diluent before use.
Reconstitution
Common laboratory method:
Add 1–2 mL bacteriostatic water slowly into the vial.
Gently swirl until the powder dissolves.
Do not shake vigorously.
Administration Route
Typically administered via subcutaneous injection in research protocols.
Common injection areas include:
Abdomen (at least 5 cm from the navel)
Outer thigh
Back of upper arm
Rotate injection sites to minimize irritation.
Suggested Dosage Guidelines (Research Use Only)
Actual dosing depends on dilution ratio and research design.
Missed Dose
If a scheduled dose is missed, administer it as soon as possible.
Do not double the next dose.
Overdose
No severe outcomes have been commonly reported in research observations.
Higher doses may result in:
Fatigue
Mild nausea
Headache
Consult a professional if overdose is suspected.
4. Possible side effects
As with other peptides used in research, side effects may occur.
Common
Injection site redness or irritation
Mild fatigue
Less common
Nausea
Temporary flushing
Rare
Allergic reactions
Skin rash
Localized vascular changes
Any adverse reactions should be reported to the research authority or supplier.
5. How to store BPC157 & TB500 10 mg
Store at 2°C – 8°C (refrigerator)
Do not freeze
Protect from heat and sunlight
Keep out of reach of children
After reconstitution:
Store refrigerated
Use within 4–6 weeks depending on protocol
Do not use if the solution becomes cloudy or discolored.
6. Contents of the pack and other informationActive Ingredients
5 mg TB-500 (Thymosin Beta-4 Acetate)
Excipients
May include:
Disodium phosphate dihydrate
Mannitol (for lyophilized stability)
Sterile water (after reconstitution)
Packaging
1 × sterile glass vial
Total peptide content: 10 mg
Product appearance:
White lyophilized powder before reconstitution
Clear solution after mixing
7. Instructions for Use (Vial)Preparation
Wash hands thoroughly.
Clean vial stopper with an alcohol swab.
Inject bacteriostatic water slowly into the vial.
Gently swirl until dissolved.
Drawing the Dose
Use a sterile insulin syringe.
Draw the desired volume based on dilution.
Remove any air bubbles.
Injection
Clean injection site.
Insert needle subcutaneously.
Inject slowly.
Dispose of the needle in a sharps container.
Important Tips
Always use new sterile syringes
Rotate injection sites
Store vial in refrigerator after use
Avoid contamination
Media ContactCompany Name: GentolexEmail: Send EmailCountry: ChinaWebsite: https://www.gentolexgroup.com/